Revive Therapeutics (RVVTF, RVV): Updates and News Archive.
Recent Headlines
(See FDA Filing Submission at Bottom)
LIVE QUOTE
Track Record
Click to open
21 clients up over $100 million, 13 clients up over ten-fold in value. Over $30 billion...
Adding VYRE Network (CAPV) to the Watch List.
Look What We Found. Our First Internet Play in Ages, And It's a Doozy.
We would categorize this...
OMNIQ (OMQS) Graduates to NASDAQ. And Three Wall Street Research Reports Follow.
Wall Street Brokerage Price Target Estimates of $15 - $18 Per Share.
Without disrupting legacy sales - CEO Shai...
Report: Ehave Inc (EHVVF) Our Favorite Psychedelic Company
WE LOOKED FAR AND WIDE TO FIND OUR FAVORITE
What exactly is a favorite?
First...
Citius Pharma (CTXR) $2.15. Price Target of $8.00 Maintained, Post Safety and Efficacy Review.
Investment Banker Buy Rating Maintained: DSMB Gives the Thumbs Up – Data in Early 2022.
CITIUS NEWS ARCHIVE
Up 191%, HealthLynked (HLYK) Reporting Decent Numbers.
Up as much as 417% from where we added it to the Watch List, the Company continues to report increasing revenues while...
Bitcoin $30,000. Time to Bargain Hunt? Read This First.
The Bit Short: Inside Crypto’s Doomsday Machine
Scary article on Tether/Bitcoin posted on...
Meet Draganfly (DFLYF) the Tesla of Drones.
A New Leader In The Drone Industry Emerges
US Government Bans Chinese Drones
Surprise...
Report: My-Cam™ and My-Cardia™ the Ultimate ‘Any-Doctor-Anywhere’ Telehealth Monitoring Application.
New and Updated Report on CB Scientific (CBSC) $1.05.
Revolutionary Any-Doctor-Any Where, at Home Heart Rate Monitor, can...
Latest article
Nine Page Summary Report on GeoVax (GOVX)
This is a great long-term story. We’re telling you.
(March 2024) When we finished writing our earlier...
GeoVax (GOVX) Provides First Half 2024 Business Update.
Award of BARDA Project NextGen contract represents a significant milestone event;
Total value...
Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.
Can You Imagine Selling Solgenix at $2.00 yesterday.
And to be honest, news wasn't all that big - such...
